SARS Pneumonia: Clinical Trials

3 trials for SARS Pneumonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Withdrawn 1
Phase 21Completed 1

Follow SARS Pneumonia: new trials by email Literature Review of SARS Pneumonia trials Research Report on SARS Pneumonia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand
Normal Saline, NDV-HXP-S vaccine - Covid-19, SARS Pneumonia
Phase 1 / Phase 2CompletedMahidol University4552021-03-202022-11-15
A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1)
COVIVAC, Phosphate-buffered saline - COVID-19 Disease, SARS Pneumonia
Phase 1CompletedInstitute of Vaccines and Medical Biologicals, Vietnam1202021-03-102025-02-13
A Study of ResCureā„¢ to Treat COVID-19 Infection
ResCureā„¢ - COVID, Covid-19
Phase 1WithdrawnProgenaBiome2020-01-012021-04-08

Narrower conditions

COVID-19 (3)  ·  Pneumonia, Viral (2)  ·  Coronavirus Infections (1)

Broader conditions

Coronaviridae Infections (3)  ·  Infections (3)  ·  Lung Diseases (3)  ·  Nidovirales Infections (3)  ·  Pneumonia (3)  ·  RNA Virus Infections (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)  ·  Virus Diseases (3)  ·  Coronavirus Infections (2)  ·  Pneumonia, Viral (1)

Interventions

COVI-VAC (1)  ·  NDV-HXP-S COVID-19 vaccine (1)  ·  Saline Solution (1)

Sponsors

Institute of Vaccines and Medical Biologicals, Vietnam (1)  ·  Mahidol University (1)  ·  ProgenaBiome (1)

Countries

Thailand (1)  ·  United States (1)  ·  Vietnam (1)

Top investigators

Punnee Pitisutthithum (1)  ·  Sabine Hazan, MD (1)

Results publications

PMID 34580673, PMID 35284808, PMID 35577631